NEW YORK (Reuters Health) – For children with bleeding disorders who experience head trauma, cranial CT scans are usually not necessary if symptoms are absent, investigators report in…
NEW YORK (Reuters Health) – Results of a large randomized, double-blind study suggest that the TNF inhibitor etanercept (Enbrel; Pfizer) may be more efficacious than sulfasalazine in the…
NEW YORK (Reuters Health) – Intravenous immunoglobulin (IVIG) is not helpful in the treatment of women with unexplained recurrent miscarriage and, for now, should not be used outside…
NEW YORK (Reuters Health) – Basal bolus glargine insulin once daily plus glulisine before meals effectively manages general surgery patients with type 2 diabetes, investigators report. Compared to…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD), an impaired platelet response clopidogrel independently contributes to worse outcomes after percutaneous coronary intervention (PCI), a…
NEW YORK (Reuters Health) – Sumatriptan given subcutaneously relieves cyclic vomiting syndrome associated with migraine, researchers from Japan report in the December 8th online Cephalalgia. “Try sumatriptan for…
NEW YORK (Reuters Health) – It is not advisable to use short-term absorbable sutures for mesh fixation after Lichtenstein inguinal hernioplasty, researchers from Sweden conclude based on review…
NEW YORK (Reuters Health) – The proton pump inhibitor dexlansoprazole modified release (MR) relieves nocturnal heartburn in patients with gastroesophageal reflux disease (GERD), study findings show. As a…
NEW YORK (Reuters Health) – Nephron-sparing surgery is linked to better survival than radical nephrectomy for renal cell carcinoma, even among patients over age 80, study findings show.…
NEW YORK (Reuters Health) – After a first myocardial infarction, treatment with a calcium-channel blocker (CCB) does not appear to diminish the efficacy of clopidogrel, according to results…